Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, August 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 253 articles:
HTML format


 

Single Articles

  1. HEALTHCARE ENGINEERING JO
    Retracted: Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer.
    J Healthc Eng. 2023;2023:9816261.
    PubMed    
    Abstract available

  2. OLLIVIER L, Moreau Bachelard C, Renaud E, Dhamelincourt E, et al
    The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review.
    Front Immunol. 2023;14:1201675.
    PubMed    
    Abstract available

  3. HIRANUMA K, Asami Y, Kato MK, Murakami N, et al
    Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.
    Cancer Med. 2023 Aug 3. doi: 10.1002/cam4.6415.
    PubMed    
    Abstract available

  4. DHAKAL K, Wang P, Mboineki JF, Getu MA, et al
    Assessment of supportive care needs among cervical cancer patients under treatment in Nepal: a cross-sectional study.
    BMC Womens Health. 2023;23:407.
    PubMed    
    Abstract available

  5. LEE SJ, Kim M, Kwak YK, Kang HJ, et al
    The impact of boost radiation therapy after hysterectomy on cervical cancer patients with close or positive resection margins.
    Clin Transl Oncol. 2023 Aug 4. doi: 10.1007/s12094-023-03283.
    PubMed    
    Abstract available

  6. HILLYAR CR, Kanabar SS, Pufal KR, Saw Hee JL, et al
    A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
    Epigenomics. 2023 Aug 3. doi: 10.2217/epi-2023-0183.
    PubMed    
    Abstract available

  7. PENG Y, Yan H, Mei W, Zhang P, et al
    Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
    Curr Treat Options Oncol. 2023 Aug 3. doi: 10.1007/s11864-023-01128.
    PubMed    
    Abstract available

  8. ILIC I, Babic G, Dimitrijevic A, Sipetic Grujicic S, et al
    Psychological Distress in Women With Abnormal Pap Smear Results Attending Cervical Cancer Screening.
    J Low Genit Tract Dis. 2023 Aug 3. doi: 10.1097/LGT.0000000000000761.
    PubMed    
    Abstract available

  9. JIANG HH, Li XF, Wang JL
    [Relationship between chronic radiation enteritis of cervical cancer and gut microbiota].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55:619-624.
    PubMed    
    Abstract available

  10. KURNIADI A, Setiawan D, Kireina J, Suardi D, et al
    Clinical and Management Dilemmas Concerning Early-Stage Cervical Cancer in Pregnancy - A Case Report.
    Int J Womens Health. 2023;15:1213-1218.
    PubMed    
    Abstract available

  11. KATAOKA Y, Fujita T, Fukunaga K, Hanaoka J, et al
    A case of primary lung cancer requiring differentiation from metastatic cervical cancer.
    Respirol Case Rep. 2023;11:e01196.
    PubMed    
    Abstract available

  12. NIYAZI M, Han L, Husaiyin S, Aishanjiang A, et al
    Analysis of somatic mutations and key driving factors of cervical cancer progression.
    Open Med (Wars). 2023;18:20230759.
    PubMed    
    Abstract available

  13. LI X, Liu H, Zhou X, Zhou Y, et al
    PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer.
    Clin Epigenetics. 2023;15:123.
    PubMed    
    Abstract available

  14. SALTA S, Lobo J, Magalhaes B, Henrique R, et al
    DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis.
    Clin Epigenetics. 2023;15:125.
    PubMed    
    Abstract available

  15. ANGULO D, Cortes MF, Mura I, Akhavan-Tabatabaei R, et al
    Fine-grained mathematical modeling for cost-effectiveness evaluation of public health policies for cervical cancer, with application to a Colombian case study.
    BMC Public Health. 2023;23:1470.
    PubMed    
    Abstract available

  16. HUGUET N, Ezekiel-Herrera D, Gunn R, Pierce A, et al
    Uptake of a Cervical Cancer Clinical Decision Support Tool: A Mixed-Methods Study.
    Appl Clin Inform. 2023;14:594-599.
    PubMed    
    Abstract available

  17. BERTAGNIN C, Messa L, Pavan M, Celegato M, et al
    A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
    Cancer Lett. 2023 Jul 31:216331. doi: 10.1016/j.canlet.2023.216331.
    PubMed    
    Abstract available

  18. XIAO T, Wang C, Yang M, Yang J, et al
    Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
    JAMA Netw Open. 2023;6:e2326890.
    PubMed    
    Abstract available

  19. HABILA MA, Sagay E, Obeng-Kusi M, Ali MJ, et al
    Utilization of opportunistic cervical cancer screening in Nigeria.
    Cancer Causes Control. 2023 Aug 2. doi: 10.1007/s10552-023-01764.
    PubMed    
    Abstract available

  20. ELLINGSON MK, Sheikha H, Nyhan K, Oliveira CR, et al
    Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review.
    Hum Vaccin Immunother. 2023;19:2239085.
    PubMed    
    Abstract available

  21. ADEKUNLE TB, Arreola A, Sembian S, Castro R, et al
    Feasibility and anticipated acceptability of community health worker-facilitated HPV self-sampling for cervical cancer screening around Lake County, Indiana.
    J Clin Transl Sci. 2023;7:e157.
    PubMed    
    Abstract available

  22. LIU S, Zhou Y, Wang C, Shen J, et al
    Prediction of lymph node status in patients with early-stage cervical cancer based on radiomic features of magnetic resonance imaging (MRI) images.
    BMC Med Imaging. 2023;23:101.
    PubMed    
    Abstract available

  23. LIU L, Liu J, Lyu Q, Huang J, et al
    Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer.
    Sci Rep. 2023;13:12470.
    PubMed    
    Abstract available

  24. WANG Y, Ma B, Li W, Li P, et al
    The efficacy of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer: A meta-analysis.
    Eur J Surg Oncol. 2023 Jul 27:106995. doi: 10.1016/j.ejso.2023.106995.
    PubMed    
    Abstract available

  25. LONG ME, Lee YS, Vegunta S
    Cervical cancer screening in menopause: when is it safe to exit?
    Menopause. 2023 Jul 25. doi: 10.1097/GME.0000000000002222.
    PubMed    
    Abstract available

  26. WEN H, Xu Q, Sheng X, Li H, et al
    Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers.
    JAMA Netw Open. 2023;6:e2326437.
    PubMed    
    Abstract available

  27. WANG Y, Yuan S, Ma J, Liu H, et al
    Substance P is overexpressed in cervical squamous cell carcinoma and promoted proliferation and invasion of cervical cancer cells in vitro.
    Eur J Histochem. 2023;67.
    PubMed    
    Abstract available

  28. LUO X, Liu J, Wang X, Yuan J, et al
    Circ-DTL sponges miR-758-3p to accelerate cervical cancer malignant progression by regulating DCUN1D1 expression.
    J Biochem Mol Toxicol. 2023 Jul 31:e23462. doi: 10.1002/jbt.23462.
    PubMed    
    Abstract available

  29. LI M, Zeng J, Chang Y, Lv L, et al
    CCT3 as a Diagnostic and Prognostic Biomarker in Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2023;33:17-28.
    PubMed    
    Abstract available

  30. RAJ S, Kattepur AK, Shylasree TS, Mishra GA, et al
    Novel educational training of para medical professionals in cervical cancer screening.
    Gynecol Oncol Rep. 2023;48:101241.
    PubMed    
    Abstract available

  31. TAN X, Wang X, Liao X, Wang X, et al
    Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1.
    iScience. 2023;26:107315.
    PubMed    
    Abstract available

  32. ALDARMAHI A, Alzahrani H, Alqutub S, Alzahrani F, et al
    Exploring the attitudes and practices of female doctors towards cervical cancer screening in primary health care centers.
    J Med Life. 2023;16:773-781.
    PubMed    
    Abstract available

  33. MURAMOTO Y, Murakami N, Karino T, Sugimoto S, et al
    MucoUp(R) as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience.
    Clin Transl Radiat Oncol. 2023;42:100659.
    PubMed    
    Abstract available

  34. LI J, Feng X, Zhu C, Jiang Y, et al
    Intact glycopeptides identified by LC-MS/MS as biomarkers for response to chemotherapy of locally advanced cervical cancer.
    Front Oncol. 2023;13:1149599.
    PubMed    
    Abstract available

  35. SHARMA J, Yennapu M, Priyanka Y
    Screening Guidelines and Programs for Cervical Cancer Control in Countries of Different Economic Groups: A Narrative Review.
    Cureus. 2023;15:e41098.
    PubMed    
    Abstract available

  36. LEPE M
    Disparities in cervical cancer screening in the United States.
    Cancer Cytopathol. 2023 Jul 31. doi: 10.1002/cncy.22752.
    PubMed    


  37. WANG T, Luan L, Deng J, Liu N, et al
    Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
    Hum Vaccin Immunother. 2023;19:2241309.
    PubMed    
    Abstract available

  38. GAO F, Wang C, Bai B, Ji J, et al
    ELK4 Promotes Cell Cycle Progression and Stem Cell-like Characteristics in HPV-associated Cervical Cancer by Regulating the FBXO22/PTEN Axis.
    Balkan Med J. 2023 Jul 31. doi: 10.4274/balkanmedj.galenos.2023.2023.
    PubMed    
    Abstract available

  39. SENIOR K
    Africa needs to boost HPV vaccine uptake to stem rise in cervical cancer.
    Lancet Oncol. 2023 Jul 27:S1470-2045(23)00380.
    PubMed    


  40. LIU Y, Chen C, Xie X, Lv X, et al
    For cervical cancer diagnosis: Tissue Raman spectroscopy and multi-level feature fusion with SENet attention mechanism.
    Spectrochim Acta A Mol Biomol Spectrosc. 2023;303:123147.
    PubMed    
    Abstract available

  41. KIM J, Jung JH, Jo H, Kim MH, et al
    Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
    Scand J Gastroenterol. 2023 Jul 30:1-10. doi: 10.1080/00365521.2023.2238101.
    PubMed    
    Abstract available

  42. MALEVOLTI MC, Maci C, Lugo A, Possenti I, et al
    Second-hand smoke exposure and cervical cancer: a systematic review and meta-analysis.
    J Cancer Res Clin Oncol. 2023 Jul 30. doi: 10.1007/s00432-023-04841.
    PubMed    
    Abstract available

  43. BAI W, Cui F, Wang Z, Gu X, et al
    Receptor-interacting protein kinase 1 (RIPK1) regulates cervical cancer cells via NF-kappaB-TNF-alpha pathway: An in vitro study.
    Transl Oncol. 2023;36:101748.
    PubMed    
    Abstract available

  44. YE X, Dong H, Wang Y, Chen Z, et al
    [Preparation and identification of rabbit anti-cyclin dependent kinase 6 (CDK6) antibodies].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023;39:742-747.
    PubMed    
    Abstract available

  45. WILLIAMSON AL
    Recent Developments in Human Papillomavirus (HPV) Vaccinology.
    Viruses. 2023;15:1440.
    PubMed    
    Abstract available

  46. REZQ KA, Algamdi M, Alanazi R, Alanazi S, et al
    Knowledge, Perception, and Acceptance of HPV Vaccination and Screening for Cervical Cancer among Saudi Females: A Cross-Sectional Study.
    Vaccines (Basel). 2023;11:1188.
    PubMed    
    Abstract available

  47. AL BAROOT A, Elsayed KA, Khan FA, Haladu SA, et al
    Anticancer Activity of Au/CNT Nanocomposite Fabricated by Nanosecond Pulsed Laser Ablation Method on Colon and Cervical Cancer.
    Micromachines (Basel). 2023;14:1455.
    PubMed    
    Abstract available

  48. HONNAVAR P, Mansoor E, Tulloch C, Udayan U, et al
    Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda.
    Medicina (Kaunas). 2023;59:1230.
    PubMed    
    Abstract available

  49. DICU-ANDREESCU IG, Marincas AM, Ungureanu VG, Ionescu SO, et al
    Current Therapeutic Approaches in Cervical Cancer Based on the Stage of the Disease: Is There Room for Improvement?
    Medicina (Kaunas). 2023;59:1229.
    PubMed    
    Abstract available

  50. PISKUR I, Topolovec Z, Bakula M, Zagorac I, et al
    Expression of Vascular Endothelial Growth Factor-A (VEGF-A) in Adenocarcinoma and Squamous Cell Cervical Cancer and Its Impact on Disease Progression: Single Institution Experience.
    Medicina (Kaunas). 2023;59:1189.
    PubMed    
    Abstract available

  51. HEO SY, Lee Y, Kim TH, Heo SJ, et al
    Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer.
    Int J Mol Sci. 2023;24:11565.
    PubMed    
    Abstract available

  52. GWAVU Z, Murray D, Okafor UB
    Perception of Women's Knowledge of and Attitudes towards Cervical Cancer and Papanicolaou Smear Screenings: A Qualitative Study in South Africa.
    Healthcare (Basel). 2023;11:2089.
    PubMed    
    Abstract available

  53. ZHOU J, Xu L, Zhou H, Wang J, et al
    Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Genes (Basel). 2023;14:1381.
    PubMed    
    Abstract available

  54. DE FIGUEIREDO FV, Santos GRBD, Vidal FCB, da Silva MACN, et al
    Impact of HPV-16 Lineages Infection in Response to Radio-Chemotherapy in Cervical Cancer.
    Biomedicines. 2023;11:2069.
    PubMed    
    Abstract available

  55. SAUSEN DG, Shechter O, Gallo ES, Dahari H, et al
    Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications.
    Cancers (Basel). 2023;15:3692.
    PubMed    
    Abstract available

  56. KALAFATI E, Drakopoulou E, Anagnou NP, Pappa KI, et al
    Developing Oncolytic Viruses for the Treatment of Cervical Cancer.
    Cells. 2023;12:1838.
    PubMed    
    Abstract available

  57. KUMAR V, Bauer C, Stewart JH 4th
    TIME Is Ticking for Cervical Cancer.
    Biology (Basel). 2023;12:941.
    PubMed    
    Abstract available

  58. SHAMSUTDINOVA A, Turdaliyeva B, Tanabayeva S, Omarova A, et al
    Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects.
    Asian Pac J Cancer Prev. 2023;24:2515-2522.
    PubMed    
    Abstract available

  59. PATEL SS, Singh N, Jamwal A, Sahu C, et al
    Comparison of Human Papillomavirus Genotype Detection in Paired Urine and Self-Collected Cervical Swabs: A Pilot Study.
    Asian Pac J Cancer Prev. 2023;24:2427-2430.
    PubMed    
    Abstract available

  60. BOSE M, Sunder Singh S, Ganesharaja S, Chiwate AS, et al
    Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
    Asian Pac J Cancer Prev. 2023;24:2337-2346.
    PubMed    
    Abstract available

  61. SEO YA, Kim YA
    Factors associated with Pap test screening among South Korean women aged 20 to 39 years.
    Medicine (Baltimore). 2023;102:e34539.
    PubMed    
    Abstract available

  62. KOTOWSKI K, Malyszczak P, Towarek M, Jagasyk A, et al
    An unusual coincidence of giant cervical leiomyoma and incidental ovarian granulosa cell tumor: A case report.
    Medicine (Baltimore). 2023;102:e34387.
    PubMed    
    Abstract available

  63. HAWARD B, Tatar O, Zhu P, Griffin-Mathieu G, et al
    Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs.
    Curr Oncol. 2023;30:7055-7072.
    PubMed    
    Abstract available

  64. ZHOU K, Yuzhakov O, Behloul N, Wang D, et al
    HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions.
    Front Immunol. 2023;14:1213285.
    PubMed    
    Abstract available

  65. GUIMARAES RIBEIRO A, Ferlay J, Pineros M, Dias de Oliveira Latorre MDR, et al
    Geographic variations in cancer incidence and mortality in the State of Sao Paulo, Brazil 2001-17.
    Cancer Epidemiol. 2023;85:102403.
    PubMed    
    Abstract available

  66. TABATABAI MK, Lophaven S, Lauenborg J, Holmager T, et al
    Socioeconomic, lifestyle and biological determinants of cervical screening coverage: Lolland-Falster Health Study, Denmark.
    Eur J Public Health. 2023;33:568-573.
    PubMed    
    Abstract available

  67. OH SH, Lee KB, Shin JW, Lee SH, et al
    Risk factors for recurrence of cervical intraepithelial neoplasia after loop electrosurgical excisional procedure in patients with positive margins.
    J Obstet Gynaecol Res. 2023;49:2102-2108.
    PubMed    
    Abstract available

  68. EGAWA N
    Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body.
    Int J Clin Oncol. 2023;28:956-964.
    PubMed    
    Abstract available

  69. QIN L
    Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2023;149:9167-9171.
    PubMed    
    Abstract available

  70. LONG L, Liu M, Deng X, Cao M, et al
    3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma.
    Magn Reson Imaging. 2023;102:62-68.
    PubMed    
    Abstract available

  71. PEDERSEN K, Kristiansen IS, Sy S, Kim JJ, et al
    Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines.
    Value Health. 2023;26:1217-1224.
    PubMed    
    Abstract available

  72. HUANG P, Zhang PF, Li Q
    Causal relationship between cannabis use and cancer: a genetically informed perspective.
    J Cancer Res Clin Oncol. 2023;149:8631-8638.
    PubMed    
    Abstract available

  73. LAI B, Luo T, Zhou J, Yang H, et al
    Cervical mixed adenocarcinoma-neuroendocrine carcinoma: A case report with liquid-based cytology.
    Asian J Surg. 2023;46:3351-3352.
    PubMed    


  74. MARCHADIER A, Bezannier L, Barre-Pierrel S, Manceau A, et al
    Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing.
    J Med Screen. 2023;30:113-119.
    PubMed    
    Abstract available

  75. HU L, Mwanahamuntu MH, Sahasrabuddhe VV, Barrett C, et al
    Validation of Automated Visual Evaluation (AVE) on Smartphone Images for Cervical Cancer Screening in a Prospective Study in Zambia.
    medRxiv. 2023 Jul 23:2023.07.19.23292888. doi: 10.1101/2023.07.19.23292888.
    PubMed    
    Abstract available

  76. ZHAO YC, Wang TJ, Qu GH, She LZ, et al
    TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior in vivo and in vitro.
    Am J Cancer Res. 2023;13:3123-3139.
    PubMed    
    Abstract available

  77. DOU Z, Zhang X, Su W, Zhang T, et al
    Indisulam exerts anticancer effects via modulation of transcription, translation and alternative splicing on human cervical cancer cells.
    Am J Cancer Res. 2023;13:2922-2937.
    PubMed    
    Abstract available

  78. LI C, Cang W, Gu Y, Chen L, et al
    The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge.
    Front Immunol. 2023;14:1195476.
    PubMed    
    Abstract available

  79. SHIMBO T, Yoshida K, Nakata M, Kobata K, et al
    KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer.
    Oncol Lett. 2023;26:378.
    PubMed    
    Abstract available

  80. LIU Q, Jiang N, Hao Y, Hao C, et al
    Identification of lymph node metastasis in pre-operation cervical cancer patients by weakly supervised deep learning from histopathological whole-slide biopsy images.
    Cancer Med. 2023 Aug 10. doi: 10.1002/cam4.6437.
    PubMed    
    Abstract available

  81. LINARES I, Berenguer Frances MA, Canas R, Najjari D, et al
    Brachytherapy for targeting the immune system in cervical cancer patients.
    BMC Immunol. 2023;24:23.
    PubMed    
    Abstract available

  82. ZHU P, Xiong J, Yuan D, Li X, et al
    ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection.
    Cell Rep Med. 2023 Aug 3:101143. doi: 10.1016/j.xcrm.2023.101143.
    PubMed    
    Abstract available

  83. ZHAO Z, Zhang J, Ren Y, Dong L, et al
    Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects.
    Bioorg Med Chem. 2023;92:117436.
    PubMed    
    Abstract available

  84. SAMBYAL D, Sarwar A
    Recent developments in cervical cancer diagnosis using deep learning on whole slide images: An Overview of models, techniques, challenges and future directions.
    Micron. 2023;173:103520.
    PubMed    
    Abstract available

  85. OPUNI RK, Adei D, Mensah AA, Adamtey R, et al
    Health needs of migrant female head porters in Ghana: evidence from the Greater Accra and Greater Kumasi Metropolitan areas.
    Int J Equity Health. 2023;22:151.
    PubMed    
    Abstract available

  86. GUILLAUME D, Moise R, Chepkorir J, Alexander K, et al
    Sociodemographics and health-literacy as predictors of cervical cancer screening practices among Haitian women: A secondary data analysis of 2016-17 DHS surveys.
    PLOS Glob Public Health. 2023;3:e0002221.
    PubMed    
    Abstract available

  87. WANBERG LJ, Kim A, Vogel RI, Sadak KT, et al
    Usability and Satisfaction Testing of Game-Based Learning Avatar-Navigated Mobile (GLAm), an App for Cervical Cancer Screening: Mixed Methods Study.
    JMIR Form Res. 2023;7:e45541.
    PubMed    
    Abstract available

  88. PERKINS RB, Wentzensen N, Guido RS, Schiffman M, et al
    Cervical Cancer Screening: A Review.
    JAMA. 2023;330:547-558.
    PubMed    
    Abstract available


  89. Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis [Retraction].
    Onco Targets Ther. 2023;16:655-656.
    PubMed    
    Abstract available


  90. Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p [Retraction].
    Cancer Manag Res. 2023;15:789-790.
    PubMed    
    Abstract available

  91. ZREIK J, Takagi MA, Akhter MF, Ahmad AA, et al
    Sociodemographic Disparities in the Diagnosis and Prognosis of Patients With Cervical Cancer: An Analysis of the Surveillance, Epidemiology, and End Results Program.
    Cureus. 2023;15:e41477.
    PubMed    
    Abstract available

  92. WANG X, Ji Y, Qi J, Zhou S, et al
    Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells.
    Cell Death Dis. 2023;14:508.
    PubMed    
    Abstract available

  93. MOHAN A, Krishnamoorthy S, Sabanayagam R, Schwenk G, et al
    Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
    Eur J Pharmacol. 2023 Aug 5:175961. doi: 10.1016/j.ejphar.2023.175961.
    PubMed    
    Abstract available

  94. GAO M, Hu S, Zhao X, You T, et al
    Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study.
    Lancet Reg Health West Pac. 2023;36:100768.
    PubMed    
    Abstract available

  95. AWAZU Y, Fukuda T, Noda T, Uchikura E, et al
    CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy.
    Oncol Lett. 2023;26:353.
    PubMed    
    Abstract available

  96. HE Y, Wang M, Yi S, Lu Y, et al
    Diffusion-weighted imaging in the assessment of cervical cancer: comparison of reduced field-of-view diffusion-weighted imaging and conventional techniques.
    Acta Radiol. 2023 Aug 6:2841851231183870. doi: 10.1177/02841851231183870.
    PubMed    
    Abstract available

  97. SABANAYAGAM R, Krishnamoorthy S, Gnanagurusamy J, Muruganatham B, et al
    EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
    Med Oncol. 2023;40:261.
    PubMed    
    Abstract available

  98. ZNAOR A, Ryzhov A, Losada ML, Carvalho A, et al
    Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: a population-based survey.
    J Cancer Policy. 2023 Aug 4:100436. doi: 10.1016/j.jcpo.2023.100436.
    PubMed    
    Abstract available

  99. AZIZIKIA H, Didar H, Teymourzadeh A, Nakhostin-Ansari A, et al
    Uterine and Cervical Cancer in Iran: An epidemiologic analysis of the Iranian National Population-Based Cancer Registry.
    Arch Iran Med. 2023;26:1-7.
    PubMed    
    Abstract available

  100. BEDNARSKA-CZERWINSKA A, Morawiec E, Zmarzly N, Szapski M, et al
    Dynamics of Microbiome Changes in the Endometrium and Uterine Cervix during Embryo Implantation: A Comparative Analysis.
    Med Sci Monit. 2023;29:e941289.
    PubMed    
    Abstract available

  101. LI X, Xiang F, Zhao Y, Li Q, et al
    Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV.
    BMC Womens Health. 2023;23:411.
    PubMed    
    Abstract available

  102. FENG W, Zhang D, Zhang R
    Correction: Circ‑ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA‑128‑3p/ZEB1 axis.
    Biol Proced Online. 2023;25:23.
    PubMed    


  103. LEE MS, Elliott NS, Bethel VD, Balise RR, et al
    Identifying Neighborhoods with Cervical Cancer Disparities for Targeted Community Outreach and Engagement by an NCI-Designated Cancer Center: A Geospatial Approach.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 4:EPI-23-0132.
    PubMed    
    Abstract available

  104. ZHANG J, Chu G, Zheng L, Liu J, et al
    Circular RNA circ_0000119 promotes cervical cancer cell growth and migration via miR-433-3p/PAK2 axis.
    J Appl Genet. 2023 Aug 4. doi: 10.1007/s13353-023-00772.
    PubMed    
    Abstract available

  105. LI J, Wang X, Li Z, Li M, et al
    SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer.
    Curr Cancer Drug Targets. 2023 Aug 4. doi: 10.2174/1568009623666230804161607.
    PubMed    
    Abstract available

  106. ERIKSEN DO, Pape M, Petersen LK, Larsen CS, et al
    [Not Available].
    Ugeskr Laeger. 2023;185:V01230005.
    PubMed    
    Abstract available

  107. FENG C, Gu L, Wei Y, Niu J, et al
    Analysis of outcomes following loop electrosurgical excision and clinical features of patients with cervical high-grade squamous intraepithelial lesions with abnormal preoperative endocervical curettage.
    World J Surg Oncol. 2023;21:237.
    PubMed    
    Abstract available

  108. EINECKE D
    [Not Available].
    MMW Fortschr Med. 2023;165:14-15.
    PubMed    


  109. BIZZARRI N, Pavone M, Loverro M, Querleu D, et al
    Ovarian preservation in gynecologic oncology: current indications and techniques.
    Curr Opin Oncol. 2023;35:401-411.
    PubMed    
    Abstract available


  110. Simple Hysterectomy Safe for Some Cervical Cancers.
    Cancer Discov. 2023;13:OF1.
    PubMed    
    Abstract available

  111. TAN JHJ, Jones A, Steele A, Vicario E, et al
    Diagnostic outcomes after colposcopy at a tertiary clinic for women aged 50-74 referred after detection of oncogenic human papillomavirus at primary screening.
    Aust N Z J Obstet Gynaecol. 2023;63:564-570.
    PubMed    
    Abstract available

  112. GILLES C, Konopnicki D, Rozenberg S
    The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model.
    HIV Med. 2023 Apr 16. doi: 10.1111/hiv.13490.
    PubMed    
    Abstract available

  113. DUPREZ D, Trauernicht C, Simonds H, Williams O, et al
    Self-configuring nnU-Net for automatic delineation of the organs at risk and target in high-dose rate cervical brachytherapy, a low/middle-income country's experience.
    J Appl Clin Med Phys. 2023;24:e13988.
    PubMed    
    Abstract available

  114. CHEN Z, Xiao Z, Tian W, Li Z, et al
    Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression.
    Iran J Public Health. 2023;52:1476-1486.
    PubMed    
    Abstract available

  115. WU X, Yu H, Bai Y, Hou Y, et al
    A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial.
    Trials. 2023;24:542.
    PubMed    
    Abstract available

  116. WOKS NIE, Anwi MM, Kefiye TB, Sama DJ, et al
    Disparities in cervical cancer screening programs in Cameroon: a scoping review of facilitators and barriers to implementation and uptake of screening.
    Int J Equity Health. 2023;22:156.
    PubMed    
    Abstract available

  117. ZHANG B, Wang S, Yang X, Chen M, et al
    Knowledge, willingness, uptake and barriers of cervical cancer screening services among Chinese adult females: a national cross-sectional survey based on a large e-commerce platform.
    BMC Womens Health. 2023;23:435.
    PubMed    
    Abstract available

  118. SPEER L
    Limited Benefit for Routine Cervical Cancer Screening With Cotesting vs. HPV Testing Alone.
    Am Fam Physician. 2023;108:204-205.
    PubMed    


  119. GJERDE PB, Tollanes MC, Trope A, Eide ML, et al
    [Not Available].
    Tidsskr Nor Laegeforen. 2023;143.
    PubMed    
    Abstract available

  120. SCHULMEYER CE, Koch MC, Dietl AK, Stuebs FA, et al
    Standardized Procedures for Patients with Dysplasia and Other Diseases of the Cervix, Vulva, and Vagina at a Certified Dysplasia Unit Prior to the Introduction of the Organized Cervical Cancer Screening Program.
    Geburtshilfe Frauenheilkd. 2023;83:1031-1042.
    PubMed    
    Abstract available

  121. FINZER P, Kuppers V, Griesser H
    Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN).
    Geburtshilfe Frauenheilkd. 2023;83:1017-1021.
    PubMed    
    Abstract available

  122. NAKASHIMA T, Matsumoto K, Yoshitake T, Wakiyama H, et al
    Transvaginal approach combined intracavitary and interstitial brachytherapy assisted by transrectal ultrasound: results from 30 patients with locally advanced cervical cancer.
    Jpn J Radiol. 2023 Aug 17. doi: 10.1007/s11604-023-01481.
    PubMed    
    Abstract available

  123. CHEN W, Xia X, Xie X, Wei Y, et al
    Nomogram for prognosis of elderly patients with cervical cancer who receive combined radiotherapy.
    Sci Rep. 2023;13:13299.
    PubMed    
    Abstract available

  124. HU S, Xu H, Xie C, Meng Y, et al
    Inhibition of human cervical cancer development through p53-dependent pathways induced by the specified triple helical beta-glucan.
    Int J Biol Macromol. 2023 Aug 14:126222. doi: 10.1016/j.ijbiomac.2023.126222.
    PubMed    
    Abstract available

  125. KUNDROD KA, Jeronimo J, Vetter B, Maza M, et al
    Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing.
    PLOS Glob Public Health. 2023;3:e0001982.
    PubMed    
    Abstract available

  126. ELEBIYO OT
    Knowledge, attitude, and uptake of Human Papilloma Virus (HPV) vaccine among parents of adolescents attending outpatient clinic at the University of Benin Teaching Hospital, Nigeria.
    Afr J Reprod Health. 2023;27:108-117.
    PubMed    
    Abstract available

  127. WARDHANA A, Dahliana A, Angkawidjaja KM
    Cervical cancer screening in former sex workers in ex-localization area.
    Afr J Reprod Health. 2023;27:45-48.
    PubMed    
    Abstract available

  128. AKPAN MI, Ndep AO, Ekpenyong BN, Akpan IA, et al
    Cervical cancer screening services targeting adult women in Cross River State, Nigeria.
    Afr J Reprod Health. 2023;27:34-42.
    PubMed    
    Abstract available

  129. ESWARAN S, Padavu M, Kumar D, Kabekkodu SP, et al
    Systematic Analysis of the Therapy Resistance Genes and Their Prognostic Relevance in Cervical Cancer.
    Curr Pharm Des. 2023 Aug 16. doi: 10.2174/1381612829666230816100623.
    PubMed    
    Abstract available

  130. TAGUCHI A, Kato K, Hara K, Furusawa A, et al
    Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group.
    Cancer Med. 2023 Aug 16. doi: 10.1002/cam4.6460.
    PubMed    
    Abstract available

  131. GONG P, Shi B, Cong X, Yang L, et al
    Multiple infections containing the top five prevalent HPV genotypes and their impact on cervical lesions in Changzhou, China.
    Hum Vaccin Immunother. 2023;19:2245723.
    PubMed    
    Abstract available

  132. LI AJ, Wang JQ, Liu HL, Lin MB, et al
    [Classification system of radical surgery for rectal cancer based on membrane anatomy].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2023;26:625-632.
    PubMed    
    Abstract available

  133. TUERXUN G, Abudurexiti G, Abulizi G
    Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China.
    BMC Womens Health. 2023;23:433.
    PubMed    
    Abstract available

  134. ORJI AF, Gimm G, Desai A, Parekh T, et al
    The Association of Cervical Cancer Screening with Disability Type among U.S. Women (25-64 years).
    Am J Prev Med. 2023 Aug 13:S0749-3797(23)00323.
    PubMed    
    Abstract available

  135. GOODMAN A
    Age cutoffs for cervical cancer screening: good medicine or ageism?
    Menopause. 2023 Aug 15. doi: 10.1097/GME.0000000000002240.
    PubMed    


  136. IRINO S, Ose H, Takata N, Kamoshida S, et al
    Barriers to undergoing cervical cancer screening among health sciences university students in Japan: A cross-sectional study.
    Nurs Health Sci. 2023 Aug 15. doi: 10.1111/nhs.13043.
    PubMed    
    Abstract available

  137. SHAO H, Li X, Wu P, Chen Z, et al
    A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
    Reprod Sci. 2023 Aug 14. doi: 10.1007/s43032-023-01305.
    PubMed    
    Abstract available

  138. NAMOOS A, Sheppard V, Abdelkarim M, Abosamak N, et al
    Exploring Factors Influencing Cervical Cancer Prevention Behaviors: Unveiling Perspectives of Conservative Muslim American Women in Virginia.
    J Relig Health. 2023 Aug 14. doi: 10.1007/s10943-023-01886.
    PubMed    
    Abstract available

  139. SONG C, Lee JJ, Lee SH, Park JY, et al
    Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.
    Nucl Med Commun. 2023 Aug 14. doi: 10.1097/MNM.0000000000001741.
    PubMed    
    Abstract available

  140. NA J, Li Y, Wang J, Wang X, et al
    The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer.
    Front Microbiol. 2023;14:1220522.
    PubMed    
    Abstract available

  141. TUCKER TC, Durbin EB, Huang B, Pictor K, et al
    Using the Incidence of Cervical Cancer Precursors to Assess the Impact of HPV Vaccination Efforts in Kentucky.
    J Registry Manag. 2023;50:34-35.
    PubMed    


  142. GARI A, Ghazzawi MA, Ghazzawi SA, Alharthi SM, et al
    Knowledge about cervical cancer risk factors and human papilloma virus vaccine among Saudi women of childbearing age: A community-based cross-sectional study from Saudi Arabia.
    Vaccine X. 2023;15:100361.
    PubMed    
    Abstract available

  143. ONG SK, Abe SK, Thilagaratnam S, Haruyama R, et al
    Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries.
    Lancet Reg Health West Pac. 2023;39:100860.
    PubMed    
    Abstract available

  144. GUSTAFSON EA, Santa Rosario JC, Rios-Bedoya C, de Socarraz M, et al
    High risk HPV testing for cervical cancer screening in a Puerto Rican population.
    Gynecol Oncol Rep. 2023;48:101236.
    PubMed    
    Abstract available

  145. SHEWA GARI F, Fenta Biru T, Endale Gurmu S
    Application of the Joint Frailty Copula Model for Analyzing Time to Relapse and Time to Death of Women with Cervical Cancer.
    Int J Womens Health. 2023;15:1295-1304.
    PubMed    
    Abstract available

  146. ALSHAMLAN NA, AlOmar RS, AlAbdulKader AM, AlGhamdi FA, et al
    Beliefs and Utilization of Cervical Cancer Screening by Female Health Care Workers in Saudi Arabia Using the Health Belief Model: A Nationwide Study.
    Int J Womens Health. 2023;15:1245-1259.
    PubMed    
    Abstract available

  147. GHOLAMALIZADEH M, Ardekanizadeh NH, Aghakhaninejad Z, Mohammadi S, et al
    The effects of dietary supplements in patients with cervical cancer: a comprehensive systematic review.
    Eur J Obstet Gynecol Reprod Biol X. 2023;19:100217.
    PubMed    
    Abstract available

  148. AUMA J, Ndawula A, Ackers-Johnson J, Horder C, et al
    Task-shifting for point-of-care cervical cancer prevention in low- and middle-income countries: a case study from Uganda.
    Front Public Health. 2023;11:1105559.
    PubMed    
    Abstract available

  149. FUSS CG, Msami K, Kahesa C, Mwaiselage J, et al
    The impact of in-house pathology services on downstaging cervical cancer in Tanzania over an 18-year period.
    Cancer Causes Control. 2023 Aug 14. doi: 10.1007/s10552-023-01768.
    PubMed    
    Abstract available

  150. SMALL C, Prior P, Nasief H, Zeitlin R, et al
    A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer.
    Brachytherapy. 2023 Aug 11:S1538-4721(23)00080.
    PubMed    
    Abstract available

  151. MOLIKA P, Bissanum R, Surachat K, Pattanapanyasat K, et al
    Exploration of extracellular vesicle long non-coding RNAs in serum of patients with cervical cancer.
    Oncology. 2023 Aug 12. doi: 10.1159/000533145.
    PubMed    
    Abstract available

  152. LI Y, Jiang YJ, Nie KH, Li J, et al
    Rational design of genotyping nanodevice for HPV subtype distinction.
    Anal Chim Acta. 2023;1276:341651.
    PubMed    
    Abstract available

  153. TYAGI A, Karapurkar JK, Colaco JC, Sarodaya N, et al
    USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression.
    Mol Biotechnol. 2023 Aug 12. doi: 10.1007/s12033-023-00814.
    PubMed    
    Abstract available

  154. AMEMIYA T, Shibata K, Yamaguchi T
    Metabolic Oscillations and Glycolytic Phenotypes of Cancer Cells.
    Int J Mol Sci. 2023;24:11914.
    PubMed    
    Abstract available

  155. HAMDI M, Senan EM, Awaji B, Olayah F, et al
    Analysis of WSI Images by Hybrid Systems with Fusion Features for Early Diagnosis of Cervical Cancer.
    Diagnostics (Basel). 2023;13:2538.
    PubMed    
    Abstract available

  156. MOKOALA KMG, Lawal IO, Maserumule LC, Bida M, et al
    Correlation between [(68)Ga]Ga-FAPI-46 PET Imaging and HIF-1alpha Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept.
    Cancers (Basel). 2023;15:3953.
    PubMed    
    Abstract available

  157. WOLSWINKEL JT, Eikelder MLGT, Verhoef CG, Zusterzeel PLM, et al
    High- or Intermediate-Risk Histologic Features in Patients with Clinical Early-Stage Cervical Cancer Planned for Fertility-Sparing Surgery: A Systematic Review.
    Cancers (Basel). 2023;15:3920.
    PubMed    
    Abstract available

  158. FARHADI A, Abuei H, Okhovat MA, Geramizadeh B, et al
    Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran.
    Cancer Cell Int. 2023;23:166.
    PubMed    
    Abstract available

  159. ZHANG J, Li X, Zhou Y, Lin M, et al
    FNBP1 Facilitates Cervical Cancer Cell Survival by the Constitutive Activation of FAK/PI3K/AKT/mTOR Signaling.
    Cells. 2023;12:1964.
    PubMed    
    Abstract available

  160. LI Y, Patterson MR, Morgan EL, Wasson CW, et al
    CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation.
    J Med Virol. 2023;95:e29025.
    PubMed    
    Abstract available

  161. NARVAEZ L, Viviano M, Dickson C, Jeannot E, et al
    The acceptability of HPV vaginal self-sampling for cervical cancer screening in Latin America: A systematic review.
    Public Health Pract (Oxf). 2023;6:100417.
    PubMed    
    Abstract available

  162. RAHAMAN A, Anantharaju A, Jeyachandran K, Manideep R, et al
    Optical imaging for early detection of cervical cancer: state of the art and perspectives.
    J Biomed Opt. 2023;28:080902.
    PubMed    
    Abstract available

  163. CHEN G, Huang K, Sun J, Yang L, et al
    Cervical neuroendocrine carcinoma in the third trimester: a rare case report and literature review.
    BMC Pregnancy Childbirth. 2023;23:571.
    PubMed    
    Abstract available

  164. JIA W, Zhao Y, Yuan P
    Circ-HMGCS1, an Indicator of Survival and Prognosis in Cervical Cancer Patients.
    Clin Lab. 2023;69.
    PubMed    
    Abstract available

  165. MEZIN L, Rousseau A, Sellier Y, Teixeira L, et al
    ["A vaccine that nonetheless remains apart": Papillomavirus and vaccination in France].
    Sante Publique. 2023;35:127-137.
    PubMed    
    Abstract available

  166. CARVALHO HA, Mauro GP
    History of radiotherapy in the treatment of uterine cervix cancer: an overview.
    Rev Assoc Med Bras (1992). 2023;69.
    PubMed    


  167. NOGUEIRA-RODRIGUES A, Rosa DD, Suzuki DA, Paulino E, et al
    Breast and gynecologic cancers as a Brazilian health priority.
    Rev Assoc Med Bras (1992). 2023;69.
    PubMed    
    Abstract available

  168. FU H, Fu Z, Mao M, Si L, et al
    Prevalence and prognostic role of PD-L1 in patients with gynecological cancers: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2023;189:104084.
    PubMed    
    Abstract available

  169. KHAMJAN NA, Beigh S, Algaissi A, Megha K, et al
    Natural and synthetic drugs and formulations for intravaginal HPV clearance.
    J Infect Public Health. 2023;16:1471-1480.
    PubMed    
    Abstract available

  170. PAL D, Samadder S, Dutta P, Roychowdhury A, et al
    Differential association of hedgehog pathway in development of cervical carcinoma and its chemo-tolerance.
    Pathol Res Pract. 2023;248:154696.
    PubMed    
    Abstract available

  171. YANG Y, Zuo S, Li W, Di M, et al
    TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.
    Pathol Res Pract. 2023;248:154710.
    PubMed    
    Abstract available

  172. MIRZAVAND BOROUJENI N, Richard JP, Sterling D, Wilke C, et al
    A linear optimization model for high dose rate brachytherapy using a novel distance metric.
    Phys Med Biol. 2023;68.
    PubMed    
    Abstract available

  173. HAGHIGHI ZMS, Tabatabaei T, Rafigh M, Karampour R, et al
    Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer.
    Pathol Res Pract. 2023;248:154653.
    PubMed    
    Abstract available

  174. GOU T, Liu P, Yao X, Zhang L, et al
    Clinical Characteristics of Human Papillomavirus Infection in the Male Genital Tract.
    Altern Ther Health Med. 2023;29:425-429.
    PubMed    
    Abstract available

  175. ZHANG J, Xie Y, Liu X, Gan L, et al
    Carbon ions trigger DNA damage response to overcome radioresistance by regulating beta-catenin signaling in quiescent HeLa cells.
    J Cell Physiol. 2023;238:1836-1849.
    PubMed    
    Abstract available

  176. OSEI EA
    Innovations in healthcare delivery: Human papilloma virus self sampling diagnostics and participatory innovations for CCS.
    Cancer Med. 2023;12:15544-15551.
    PubMed    
    Abstract available

  177. MWAMBA M, Lombe DC, Msadabwe S, Bond V, et al
    A Narrative Synthesis of Literature on the Barriers to Timely Diagnosis and Treatment of Cancer in Sub-Saharan Africa.
    Clin Oncol (R Coll Radiol). 2023;35:e537-e548.
    PubMed    
    Abstract available

  178. HABARA K, Nishikori A, Kiyama J, Nakashima M, et al
    A case of coexistent poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), usual-type adenocarcinoma, and squamous cell carcinoma in situ of the cervix.
    Med Mol Morphol. 2023;56:217-224.
    PubMed    
    Abstract available

  179. SATO M, Inoue A, Takasawa A, Takasawa K, et al
    Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus.
    Med Mol Morphol. 2023;56:187-193.
    PubMed    
    Abstract available

  180. RAJENDRAN S, McGivern U, Gonzalez D, McCluggage WG, et al
    Cervical Gastric-type Adenosquamous Carcinoma: Case Report of a Rare Neoplasm Associated With a BRCA1 Pathogenic Variant.
    Int J Gynecol Pathol. 2023;42:529-534.
    PubMed    
    Abstract available

  181. MALAGON T, Trottier H, El-Zein M, Villa LL, et al
    Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women.
    J Infect Dis. 2023;228:402-411.
    PubMed    
    Abstract available

  182. AND BIOMECHANICS AB
    Retracted: Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review.
    Appl Bionics Biomech. 2023;2023:9894241.
    PubMed    
    Abstract available

  183. AND BIOMECHANICS AB
    Retracted: Construction of Nursing Practice Model in Case Management of Concurrent Chemotherapy and Radiochemotherapy Treatment in Cervical Cancer.
    Appl Bionics Biomech. 2023;2023:9826491.
    PubMed    
    Abstract available

  184. GUTHRIE L, Mkandawire J, Stevenson E, Bonya S, et al
    Lessons in Cultural Adaptations: Translation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module From English to Chichewa in Malawi.
    J Surg Res. 2023;292:150-157.
    PubMed    
    Abstract available

  185. WANG L, Wang Y, Wang C, Yang K, et al
    CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer.
    J Mol Histol. 2023 Aug 24. doi: 10.1007/s10735-023-10145.
    PubMed    
    Abstract available

  186. SUDHAKARAN S, Bhatla N, Mathur SR, Mahey R, et al
    Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm.
    Natl Med J India. 2023;36:17-21.
    PubMed    
    Abstract available

  187. VINOKUROV MA, Mironov KO, Domonova EA, Romanyuk TN, et al
    The genetic variant rs55986091 HLA-DQB1 is associated with a protective effect against cervical cancer.
    Front Oncol. 2023;13:1207935.
    PubMed    
    Abstract available

  188. DING X, Zhang Y, Wang J, Huang A, et al
    The association of adverse reactions and depression in cervical cancer patients treated with radiotherapy and/or chemotherapy: moderated mediation models.
    Front Psychol. 2023;14:1207265.
    PubMed    
    Abstract available

  189. DHAKAL K, Chen C, Wang P, Mboineki JF, et al
    The supportive care needs survey short form 34 (SCNS-SF34): translation and cultural adaptation into the Nepali language among patients with cervical cancer in Nepal.
    Health Qual Life Outcomes. 2023;21:98.
    PubMed    
    Abstract available

  190. MUSA J, Kocherginsky M, Magaji FA, Maryam AJ, et al
    Epidemiology and Survival outcomes of HIV-associated cervical cancer in Nigeria.
    medRxiv. 2023 Aug 13:2023.08.08.23293820. doi: 10.1101/2023.08.08.23293820.
    PubMed    
    Abstract available

  191. KUMAR N, Kalyani KP, Sharma A, Sivakoti S, et al
    "Uncommon location for a common disease, simulating cervical cancer: A rare case report".
    Infect Disord Drug Targets. 2023 Aug 22. doi: 10.2174/1871526523666230822155148.
    PubMed    
    Abstract available

  192. DO NASCIMENTO MEDEIROS JA, Sarmento ACA, Bernardes-Oliveira E, de Oliveira R, et al
    Evaluation of Exosomal miRNA as Potential Biomarkers in Cervical Cancer.
    Epigenomes. 2023;7:16.
    PubMed    
    Abstract available

  193. GHOSH S, Fantes J, Leschly K, Mazul J, et al
    Electronic data review, client reminders, and expanded clinic hours for improving cervical cancer screening rates after COVID-19 pandemic shutdowns: a multi-component quality improvement program.
    Elife. 2023;12:e85724.
    PubMed    
    Abstract available

  194. GUVEN CM, Ozgur A
    BIIB021, an orally available and small-molecule inhibitor of HSP90, activates intrinsic apoptotic pathway in human cervical adenocarcinoma cell line (HeLa).
    Eur Rev Med Pharmacol Sci. 2023;27:7299-7308.
    PubMed    
    Abstract available

  195. SHENG N, He C, Jin X, Meng Q, et al
    A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
    J Gene Med. 2023 Aug 22:e3581. doi: 10.1002/jgm.3581.
    PubMed    
    Abstract available

  196. SU CH, Hsu PS, Lin CS
    Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
    BMC Health Serv Res. 2023;23:878.
    PubMed    
    Abstract available

  197. WU L, Tan Y, Zhang H, Guo P, et al
    A Laser Free Self-luminous Nanosystem for Photodynamic Therapy of Cervical Cancer Cells.
    Photodiagnosis Photodyn Ther. 2023 Aug 19:103756.
    PubMed    
    Abstract available

  198. COLLARINO A, Florit A, Bizzarri N, Lanni V, et al
    Radioguided surgery with beta decay: A feasibility study in cervical cancer.
    Phys Med. 2023;113:102658.
    PubMed    
    Abstract available

  199. CHAIWIANG N, Poyomtip T
    Toll-Like Receptor Polymorphisms and the Risk of Cancer: Meta-analysis Study.
    Methods Mol Biol. 2023;2700:179-185.
    PubMed    
    Abstract available

  200. OLUWADAMILOLA MIRIAM K, Rosemary IA, Adebimpe IW, Olusola AM, et al
    Formulation and evaluation of paclitaxel-loaded boronated chitosan/alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery.
    J Drug Deliv Sci Technol. 2023;87:104810.
    PubMed    
    Abstract available

  201. HOU J, Zeng M, Liu C, Xie B, et al
    Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.
    Front Public Health. 2023;11:1210253.
    PubMed    
    Abstract available

  202. ZHANG Y, Tian F, Zhao J
    MiR-520d-3p suppresses the proliferation and epithelial-mesenchymal transition of cervical cancer cells by targeting ZFP36L2.
    Heliyon. 2023;9:e18789.
    PubMed    
    Abstract available

  203. GUO L, Su Y, Liu X, Xie W, et al
    Serum cell division cycle 42 reflects the treatment response and survival in patients with advanced cervical cancer who receive immune checkpoint inhibitor treatment.
    Oncol Lett. 2023;26:414.
    PubMed    
    Abstract available

  204. MAO Y, Jiang X, Guo P, Ouyang Y, et al
    ZXDC enhances cervical cancer metastasis through IGF2BP3-mediated activation of RhoA/ROCK signaling.
    iScience. 2023;26:107447.
    PubMed    
    Abstract available

  205. GHOSH A, Ghosh A, Sinha A, Mathai S, et al
    Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy.
    Tumour Biol. 2023;45:55-69.
    PubMed    
    Abstract available

  206. ALGHAMDI S, Baeissa HM, Azhar Kamal M, Rafeeq MM, et al
    Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
    J Biomol Struct Dyn. 2023 Aug 20:1-13. doi: 10.1080/07391102.2023.2248260.
    PubMed    
    Abstract available

  207. LIN E, Sleboda P, Rimel BJ, Chen JT, et al
    Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity.
    Cancer Causes Control. 2023 Aug 21. doi: 10.1007/s10552-023-01771.
    PubMed    
    Abstract available

  208. ZHENG F, Wang K
    The impact of social media on guideline-concordant cervical cancer-screening: insights from a national survey.
    Public Health. 2023;223:50-56.
    PubMed    
    Abstract available

  209. TRUJILLO-CIRILO L, Weiss-Steider B, Vargas-Angeles CA, Corona-Ortega MT, et al
    Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion.
    Cytokine. 2023;170:156334.
    PubMed    
    Abstract available

  210. LE-TRUNG N, Duong TM, Dang TTP, Kamei K, et al
    Potent anti-cancer activity of Sphaerocoryne affinis fruit against cervical cancer HeLa cells via inhibition of cell proliferation and induction of apoptosis.
    BMC Complement Med Ther. 2023;23:290.
    PubMed    
    Abstract available

  211. XIN S, Jianbo Y, Chen J
    Analysis of treatment strategies for patients with advanced cervical cancer and obstructive renal failure after failure of ureteral catheterization.
    Asian J Surg. 2023 Aug 17:S1015-9584(23)01228.
    PubMed    


  212. CAMARA H, Nosi S, Munnull G, Badman SG, et al
    "This is really something: same place, same day result, same day treatment" women's experiences of testing positive for HPV and receiving same-day treatment in Papua New Guinea: an interpretative phenomenological analysis.
    BMC Womens Health. 2023;23:438.
    PubMed    
    Abstract available

  213. GIUFFRE G, Iacobellis M
    Re: '2020 list of human papillomavirus assays suitable for primary cervical cancer screening' by arbyn et al.
    Clin Microbiol Infect. 2023 Aug 16:S1198-743X(23)00390.
    PubMed    


  214. KIBRET YM, Tigeneh W, Jemal A, Kantelhardt EJ, et al
    Implementation of Brachytherapy for Patients With Cervical Cancer in Ethiopia: A 3-Year Practice Report.
    JCO Glob Oncol. 2023;9:e2200407.
    PubMed    
    Abstract available

  215. COBUSSEN A, Petric P, Wulff CN, Buus S, et al
    Clinical outcomes using a 3D printed tandem-needle-template and the EMBRACE-II planning aims for image guided adaptive brachytherapy in locally advanced cervical cancer.
    Acta Oncol. 2023 Aug 18:1-9. doi: 10.1080/0284186X.2023.2246642.
    PubMed    
    Abstract available

  216. LI D, Huang Y, Wei M, Chen B, et al
    Overexpression of SOCS2 Inhibits EMT and M2 Macrophage Polarization in Cervical Cancer via IL-6/JAK2/STAT3 Pathway.
    Comb Chem High Throughput Screen. 2023.
    PubMed    
    Abstract available

  217. NING Y, Liu Y, Zeng D, Zhou Y, et al
    Patterns of lymph node metastasis in level IIB and contralateral level VI for papillary thyroid carcinoma with pN1b and safety of low collar extended incision for neck dissection in level II.
    World J Surg Oncol. 2023;21:249.
    PubMed    
    Abstract available

  218. FLOYD-ELLIS V, Taylor A
    Dermatomyositis: a debilitating paraneoplastic phenomenon following a diagnosis of localised squamous cell carcinoma of the cervix.
    BMJ Case Rep. 2023;16:e253640.
    PubMed    
    Abstract available

  219. BRUNI L, Albero G, Rowley J, Alemany L, et al
    Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
    Lancet Glob Health. 2023;11:e1345-e1362.
    PubMed    
    Abstract available

  220. APPIAH LC, Moravek M, Hoefgen H, Rotz S, et al
    Reproductive late effects after hematopoietic stem cell transplant in pediatric, adolescent, and young adult cancer survivors.
    Pediatr Blood Cancer. 2023;70 Suppl 5:e30551.
    PubMed    
    Abstract available

  221. POLJAK M, Cuschieri K, Alemany L, Vorsters A, et al
    Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory.
    J Clin Microbiol. 2023;61:e0140322.
    PubMed    
    Abstract available

  222. PARVEEN S, Kumar S, Pal S, Yadav NP, et al
    Enhanced therapeutic efficacy of Piperlongumine for cancer treatment using nano-liposomes mediated delivery.
    Int J Pharm. 2023;643:123212.
    PubMed    
    Abstract available

  223. KEALEY MR, Urakami J, Henderson K, Chignell M, et al
    In what ways does user experience design improve printed educational materials?
    Appl Ergon. 2023;113:104081.
    PubMed    
    Abstract available

  224. HOEFGEN HR, Benoit J, Chan S, Jayasinghe Y, et al
    Female reproductive health in pediatric, adolescent, and young adult cancer survivors.
    Pediatr Blood Cancer. 2023;70 Suppl 5:e29170.
    PubMed    
    Abstract available

  225. LATSUZBAIA A, Vanden Broeck D, Van Keer S, Weyers S, et al
    Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
    J Mol Diagn. 2023;25:702-708.
    PubMed    
    Abstract available

  226. HWANG JH, Kim BW
    The incidence of perioperative lymphatic complications after radical hysterectomy and pelvic lymphadenectomy between robotic and laparoscopic approach : a systemic review and meta-analysis.
    Int J Surg. 2023;109:2478-2485.
    PubMed    
    Abstract available

  227. XUE P, Xu HM, Tang HP, Weng HY, et al
    Improving the Accuracy and Efficiency of Abnormal Cervical Squamous Cell Detection With Cytologist-in-the-Loop Artificial Intelligence.
    Mod Pathol. 2023;36:100186.
    PubMed    
    Abstract available

  228. KIR G, Dokmeci Guney D, Seneldir H
    Comparison of the Clinical Performance of Aptima HPV Assay and the Cobas 4800 Platform in Women with Normal Cytology and Positive High-Risk HPV.
    Acta Cytol. 2023;67:395-402.
    PubMed    
    Abstract available

  229. XUE P, Xu HM, Tang HP, Wu WQ, et al
    Assessing artificial intelligence enabled liquid-based cytology for triaging HPV-positive women: a population-based cross-sectional study.
    Acta Obstet Gynecol Scand. 2023;102:1026-1033.
    PubMed    
    Abstract available

  230. DAMGAARD RK, Jenkins D, Stoler MH, van de Sandt MM, et al
    High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Acta Obstet Gynecol Scand. 2023;102:1227-1235.
    PubMed    
    Abstract available

  231. SOARES LC, de Souza RJ, Oliveira MAP
    Reviewing FIGO 2018 cervical cancer staging.
    Acta Obstet Gynecol Scand. 2023 Aug 17. doi: 10.1111/aogs.14667.
    PubMed    


  232. VADAPARAMPIL ST, Fuzzell LN, Brownstein NC, Fontenot HB, et al
    A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Cancer. 2023;129:2671-2684.
    PubMed    
    Abstract available

  233. DING S, Li H
    Re: A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Eur J Cancer. 2023 Aug 1:112978. doi: 10.1016/j.ejca.2023.112978.
    PubMed    


  234. KHAN A, Hussain S, Iyer JK, Kaul A, et al
    Human papillomavirus-mediated expression of complement regulatory proteins in human cervical cancer cells.
    Eur J Obstet Gynecol Reprod Biol. 2023;288:222-228.
    PubMed    
    Abstract available

  235. KONG TW, Kim J, Son JH, Lee AJ, et al
    Is minimally invasive radical surgery safe for patients with cervical cancer
    Gynecol Oncol. 2023;176:122-129.
    PubMed    
    Abstract available

  236. KOROMPELIS P, Rundle S, Cassar V, Ratnavelu N, et al
    "Conservative surgical approaches for small volume FIGO stage IB1 cervical cancer. Updated survival and obstetric outcomes of an expanded cohort".
    Gynecol Oncol. 2023;176:155-161.
    PubMed    
    Abstract available

  237. LIU Y, He J, Liu P, Chen C, et al
    Postoperative management of FIGO 2018 stage IIA1 cervical squamous cell carcinoma with only one intermediate-risk factor: Is radiotherapy needed?
    Int J Gynaecol Obstet. 2023;162:1098-1105.
    PubMed    
    Abstract available

  238. ZHOU Y, Wang C, Li W, Lu W, et al
    Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial.
    Int J Gynaecol Obstet. 2023;162:969-976.
    PubMed    
    Abstract available

  239. GONZALEZ-OCHOA E, Milosevic M, Corr B, Abbruzzese JL, et al
    A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
    Int J Gynecol Cancer. 2023;33:1208-1214.
    PubMed    
    Abstract available

  240. MAURO J, Viveros-Carreno D, Vizzielli G, De Ponti E, et al
    Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 Aug 16:ijgc-2023-004692.
    PubMed    
    Abstract available

  241. KUMAR A, Gurram L, Nayak P, Mulye G, et al
    Correlation of haematological parameters with clinical outcomes in cervical cancer patients treated with radical radio (chemo) therapy - A retrospective study.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07677.
    PubMed    
    Abstract available

  242. LAVILLE A, Ka K, El-Ayachi R, Achkar S, et al
    Locoregional treatment in patients with metastatic cervical cancer: benefit of dose escalation strategies.
    Int J Radiat Oncol Biol Phys. 2023 Aug 14:S0360-3016(23)07744.
    PubMed    
    Abstract available

  243. CHO WK, Kim HS, Park W, Kim YS, et al
    The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
    Int J Radiat Oncol Biol Phys. 2023;117:154-163.
    PubMed    
    Abstract available

  244. ALIMENA S, Lykken JM, Tiro JA, Chubak J, et al
    Timing of Colposcopy and Risk of Cervical Cancer.
    Obstet Gynecol. 2023 Aug 22. doi: 10.1097/AOG.0000000000005313.
    PubMed    
    Abstract available

  245. SINHA N, McDonald A, Barry D, Barber EL, et al
    Large Publication Gap for Gynecologic Cancers in High-Impact Factor Journals.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005301.
    PubMed    
    Abstract available

  246. YILMAZ E, Lagheden C, Ghaderi M, Wang J, et al
    Assessment of Human Papillomavirus Non-16/18, Type-Specific Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse Among Women With Cervical Atypical Glandular Cells.
    Obstet Gynecol. 2023;142:679-687.
    PubMed    
    Abstract available

  247. NOUT R, Calaminus G, Planchamp F, Chargari C, et al
    ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer.
    Radiother Oncol. 2023;186:109662.
    PubMed    
    Abstract available

  248. DADIPOOR S, Alavi A, Kader Z, Mohseni S, et al
    Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.
    BMC Cancer. 2023;23:730.
    PubMed    
    Abstract available

  249. BAS S, Sijben J, Bischoff EWMA, Bekkers RLM, et al
    Acceptability of risk-based triage in cervical cancer screening: A focus group study.
    PLoS One. 2023;18:e0289647.
    PubMed    
    Abstract available

  250. CONTRERAS NE, Roldan JS, Castillo DS
    Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
    PLoS One. 2023;18:e0290088.
    PubMed    
    Abstract available

  251. CHONA EZ, Msengi EA, Gosse RA, Ambikile JS, et al
    The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania.
    PLoS One. 2023;18:e0289925.
    PubMed    
    Abstract available

  252. OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al
    The psychosocial burden of women seeking treatment for breast and cervical cancers in Ghana's major cancer hospitals.
    PLoS One. 2023;18:e0289055.
    PubMed    
    Abstract available

  253. GONG M, Shen F, Li Y, Ming L, et al
    MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    PLoS One. 2023;18:e0290462.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;